Last reviewed · How we verify
NCT06694870
Transcutaneous CO2 Measurement - From Hospital to Home
trial testing Transcutaneous CO2 monitoring in Type 2 Respiratory Failure in 129 participants. Completed in 31 December 2022.
31 December 2022
Quick facts
| Lead sponsor | University of Oslo |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 129 |
| Start date | 1 January 2020 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Transcutaneous CO2 monitoring
Conditions studied
- Type 2 Respiratory Failure — all drugs for Type 2 Respiratory Failure →
- Hypercapnic Respiratory Failure — all drugs for Hypercapnic Respiratory Failure →
Sponsor
University of Oslo
Who can join
18 and older, any sex, with Type 2 Respiratory Failure or Hypercapnic Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Long-term non-invasive ventilation (LT-NIV) is the main treatment modality for chronic hypercapnic respiratory failure.To assess the adequacy of alveolar ventilation during sleep and potential sleep hypoventilation, nocturnal transcutaneous CO2 (PtcCO2) monitoring is necessary. There is an increased tendency to monitor patients at home, but there is a lack of robust data comparing the technical success rates between the home and inpatient setting of PtcCO2 monitoring. The primary aim of the current study was to evaluate the rate of successful nocturnal PtcCO2 monitoring in a home setting in a population of patients with chronic hypercapnic respiratory failure receiving LT-NIV. The secondary aim was to compare these data with PtcCO2 registrations performed during regular follow up of a similar population of patients in a hospital setting.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06694870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcutaneous CO2 monitoring
Trials testing the same drug.
- NCT03478566 — Transcutaneous CO2 Monitoring at Home for Children With Neuromuscular Disease · NA · active not recruiting
Other University of Oslo trials
Trials by the same sponsor.
- NCT07346911 — Digital Interventions for Relapse Prevention in Adolescence · NA · not yet recruiting
- NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
- NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
- NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
- NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06694870 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oslo
- Last refreshed: 19 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06694870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing